VIR
Vir Biotechnology Inc
11.50$
-0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.5% | 82.8% | 67.6% | 72.2% | 69.9% | 74.5% | 71.3% | 61.7% | 53.5% | 51.3% | 51.0% | 47.2% | |
| 22.1% | 12.6% | 9.0% | 17.8% | 11.2% | 15.9% | 20.9% | 17.7% | 16.7% | 23.3% | 26.9% | 22.9% | |
| 83.0% | 79.3% | 64.1% | 68.9% | 61.0% | 64.7% | 61.3% | 50.8% | 49.7% | 46.2% | 46.1% | 43.5% | |
| 0.2% | 0.6% | 0.5% | 0.4% | 0.4% | 0.4% | – | 0.4% | 0.4% | 0.4% | – | 1.8% | |
| 0.4% | – | – | 0.0% | -0.4% | – | – | – | – | – | – | – | |
| 0.8% | 0.9% | 0.9% | 1.0% | 1.1% | 1.2% | 1.3% | 1.4% | 1.7% | 1.7% | 1.7% | 1.4% | |
| 1.2% | 1.2% | 1.3% | 1.1% | 1.3% | 0.6% | 0.6% | 0.7% | 0.8% | 0.8% | 0.8% | 0.6% | |
| 18.1% | 17.1% | 13.7% | 14.1% | 17.2% | 17.8% | 20.2% | 20.5% | 21.9% | 23.7% | 20.8% | 19.1% | |
| 8.1% | 9.1% | 5.2% | 5.8% | 7.8% | 8.6% | 10.5% | 8.8% | 7.4% | 9.3% | 7.2% | 7.8% | |
| 0.7% | 0.7% | 0.7% | 1.2% | 1.3% | 0.6% | 0.6% | 0.7% | 0.9% | 0.9% | 0.9% | 0.8% | |
| 0.2% | 0.3% | 0.4% | 0.3% | 0.5% | 0.4% | 0.3% | 1.0% | 0.7% | 1.0% | 0.5% | 1.5% | |
| 81.9% | 82.9% | 86.3% | 85.9% | 82.8% | 82.2% | 79.8% | 79.5% | 78.1% | 76.3% | 79.2% | 80.9% | |
| -6.0% | -12.4% | -16.9% | -26.4% | -43.7% | -54.3% | -67.3% | -83.2% | -113.3% | -119.4% | -129.0% | -102.4% | |
| 6.6% | 7.0% | 7.5% | 8.2% | 9.1% | 9.8% | 10.5% | 11.6% | 13.6% | 13.9% | 14.4% | 13.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.